Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy

Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy have?

Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy has 84 citations in the OpenAlex counts ScholarIQ stores.

When was Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy published?

Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy has 2017 year in the ScholarIQ index.

What is the open-access status of Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy?

Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy has bronze oa status in the ScholarIQ index.

What is the DOI of Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy?

The DOI for Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy is on the source record.

What is the PMID of Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy?

The PMID for Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy is on the source record.

What is the OpenAlex record for Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy?

The OpenAlex for Inverse remodelling of K_2P3.1 K⁺channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy is on the source record.